Brown Advisory
VYNT

Brown Advisory’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Brown Advisory’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-107
Closed -$28K – 1164
2016
Q3 		$28K Sell
107
-13
-11% -$3.98K ﹤0.01% 1062
2016
Q2 		$36K Buy
+120
New +$42.2K ﹤0.01% 1036

Other funds holding VYNT

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $169M AUM 12.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Brown Advisory's VYNT Position: Q4 2016 in Review

Brown Advisory sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2016, closing a stake of 107 shares — an estimated $28K sold.

Brown Advisory first reported a position in VYNT in Q2 2016 and held it in 2 quarters. The position peaked at $36K in Q2 2016. 29 funds tracked by Wall St. Rank hold VYNT as of Q4 2016.

  • Brown Advisory reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Brown Advisory sold 107 Vyant Bio, Inc. Common Stock shares in Q4 2016, an estimated $28K.
  • Brown Advisory first reported a position in Vyant Bio, Inc. Common Stock in Q2 2016 and held it in 2 quarters.
  • Brown Advisory's Vyant Bio, Inc. Common Stock position peaked at $36K in Q2 2016.
  • 29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2016.

Based on Brown Advisory's 13F filing for Q4 2016, filed 13 Feb 2017.